内分泌指南

订阅

MedSci主页 / 所有栏目 / 内分泌指南

2022 AAN实践指南：疼痛性糖尿病性多发性神经病的口服药物和局部治疗（更新版）

2021-12-30 美国神经病学学会 Neurology

神经变性疾病糖尿病性多发性神经病疼痛性糖尿病性多发性神经病

美国神经病学学会(AAN)更新了疼痛性糖尿病性多发性神经病的口服药物和局部治疗指南。本文是对2011年糖尿病周围神经痛治疗指南的更新，主要内容聚焦局部以及口服药物治疗。

中文标题：

2022 AAN实践指南：疼痛性糖尿病性多发性神经病的口服药物和局部治疗（更新版）

英文标题：

Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee

发布机构：

美国神经病学学会

发布日期：

2021-12-30

简要介绍：

美国神经病学学会(AAN)更新了疼痛性糖尿病性多发性神经病的口服药物和局部治疗指南。本文是对2011年糖尿病周围神经痛治疗指南的更新，主要内容聚焦局部以及口服药物治疗。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2022 AAN实践指南：疼痛性糖尿病性多发性神经病的口服药物和局部治疗（更新版）.pdf)] GetToolGuiderByIdResponse(projectId=1, id=3d12f1c002309e0d, title=2022 AAN实践指南：疼痛性糖尿病性多发性神经病的口服药物和局部治疗（更新版）, enTitle=Oral and Topical Treatment of Painful Diabetic Polyneuropathy: Practice Guideline Update Summary: Report of the AAN Guideline Subcommittee, guiderFrom=Neurology, authorId=0, author=, summary=美国神经病学学会(AAN)更新了疼痛性糖尿病性多发性神经病的口服药物和局部治疗指南。本文是对2011年糖尿病周围神经痛治疗指南的更新，主要内容聚焦局部以及口服药物治疗。, cover=https://img.medsci.cn/202211/1641025777670_1608702.jpg, journalId=0, articlesId=null, associationId=37, associationName=美国神经病学学会, associationIntro=美国神经病学学会成立于1948年，是一个由24,000神经学家和神经科专业人士国际性的专业学会，它致力于推动以病人为中心的，最高质量的神经疾病的治疗。每名神经病学家均是在脑以及神经系统疾病的诊断，治疗和处理方面经过专业培训的医生。其官方期刊是Neurology。学会开发临床实践指南，每个指南具体的临床建议，都是基于严格的和所有可行的科学数据进行的综合评价制定的。, copyright=0, guiderPublishedTime=Thu Dec 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">美国神经病学学会(AAN)更新了疼痛性糖尿病性多发性神经病的口服药物和局部治疗指南。本文是对2011年糖尿病周围神经痛治疗指南的更新，主要内容聚焦局部以及口服药物治疗。</span></p>, tagList=[TagDto(tagId=5308, tagName=神经变性疾病), TagDto(tagId=120741, tagName=糖尿病性多发性神经病), TagDto(tagId=120742, tagName=疼痛性糖尿病性多发性神经病)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌, tenant=100), CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=216, guiderKeyword=糖尿病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=1, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=205398, appHits=130, showAppHits=0, pcHits=463, showPcHits=205267, likes=1, shares=8, comments=10, approvalStatus=1, publishedTime=Sat Jan 01 16:22:40 CST 2022, publishedTimeString=2021-12-30, pcVisible=1, appVisible=1, editorId=1608702, editor=dajiong, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=dajiong, createdTime=Sat Jan 01 16:29:59 CST 2022, updatedBy=1608702, updatedName=dajiong, updatedTime=Sat Jan 06 15:22:30 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2022 AAN实践指南：疼痛性糖尿病性多发性神经病的口服药物和局部治疗（更新版）.pdf)])
2022 AAN实践指南：疼痛性糖尿病性多发性神经病的口服药物和局部治疗（更新版）.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1185439, encodeId=7b971185439fd, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:12 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180789, encodeId=e9b91180e8996, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Wed Jan 05 09:41:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180041, encodeId=6c7f1180041b6, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:26:27 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180161, encodeId=227e11801612b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dglMUGgevnib2TUNdKibb54sKOs3aTWAQjREfsWCaJZtWFAhkW8cDHBwx0UMhEI7CfRZaicZZqhMLcQMwcneOkbGQ/132, createdBy=10a92340475, createdName=1228d32am78(暂无昵称), createdTime=Mon Jan 03 21:14:22 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179909, encodeId=2d1211e99096e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Jan 03 01:41:02 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-18 ms6000000807686529

    👍👍👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1185439, encodeId=7b971185439fd, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:12 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180789, encodeId=e9b91180e8996, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Wed Jan 05 09:41:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180041, encodeId=6c7f1180041b6, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:26:27 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180161, encodeId=227e11801612b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dglMUGgevnib2TUNdKibb54sKOs3aTWAQjREfsWCaJZtWFAhkW8cDHBwx0UMhEI7CfRZaicZZqhMLcQMwcneOkbGQ/132, createdBy=10a92340475, createdName=1228d32am78(暂无昵称), createdTime=Mon Jan 03 21:14:22 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179909, encodeId=2d1211e99096e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Jan 03 01:41:02 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-05 胡国宏

    #学习#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1185439, encodeId=7b971185439fd, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:12 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180789, encodeId=e9b91180e8996, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Wed Jan 05 09:41:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180041, encodeId=6c7f1180041b6, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:26:27 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180161, encodeId=227e11801612b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dglMUGgevnib2TUNdKibb54sKOs3aTWAQjREfsWCaJZtWFAhkW8cDHBwx0UMhEI7CfRZaicZZqhMLcQMwcneOkbGQ/132, createdBy=10a92340475, createdName=1228d32am78(暂无昵称), createdTime=Mon Jan 03 21:14:22 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179909, encodeId=2d1211e99096e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Jan 03 01:41:02 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-03 一己怀

    学习学习学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1185439, encodeId=7b971185439fd, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:12 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180789, encodeId=e9b91180e8996, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Wed Jan 05 09:41:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180041, encodeId=6c7f1180041b6, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:26:27 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180161, encodeId=227e11801612b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dglMUGgevnib2TUNdKibb54sKOs3aTWAQjREfsWCaJZtWFAhkW8cDHBwx0UMhEI7CfRZaicZZqhMLcQMwcneOkbGQ/132, createdBy=10a92340475, createdName=1228d32am78(暂无昵称), createdTime=Mon Jan 03 21:14:22 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179909, encodeId=2d1211e99096e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Jan 03 01:41:02 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-03 1228d32am78(暂无昵称)

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1185439, encodeId=7b971185439fd, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=100, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c8c25597134, createdName=ms6000000807686529, createdTime=Tue Jan 18 03:35:12 CST 2022, time=2022-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180789, encodeId=e9b91180e8996, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/949453D13700D5D5E2170BDB0CBBEB81/100, createdBy=66e32451407, createdName=胡国宏, createdTime=Wed Jan 05 09:41:18 CST 2022, time=2022-01-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180041, encodeId=6c7f1180041b6, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=116, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d25a5516768, createdName=一己怀, createdTime=Mon Jan 03 16:26:27 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1180161, encodeId=227e11801612b, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/dglMUGgevnib2TUNdKibb54sKOs3aTWAQjREfsWCaJZtWFAhkW8cDHBwx0UMhEI7CfRZaicZZqhMLcQMwcneOkbGQ/132, createdBy=10a92340475, createdName=1228d32am78(暂无昵称), createdTime=Mon Jan 03 21:14:22 CST 2022, time=2022-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1179909, encodeId=2d1211e99096e, content=学习学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=47445626421, createdName=ms6000001387765207, createdTime=Mon Jan 03 01:41:02 CST 2022, time=2022-01-03, status=1, ipAttribution=)]
    2022-01-03 ms6000001387765207

    学习学习学习

    0

相关指南

帕金森病(颤拘病)中医临床诊疗专家共识

广州中医药大学第二附属医院 · 2021-11-26

痴呆诊断中 PET 临床合理化应用中国专家共识 (2021版)

中国微循环学会神经变性病专业委员会 · 2021-11-25

中西医结合治疗早期帕金森病专家共识(2021)

上海市中医药学会神经科分会 · 2021-11-02

2021 EAN/ESRS欧洲指南：成人和儿童发作性睡病的治疗

欧洲神经病学学会(EAN,European Academy of Neurology) · 2021-06-25

2021 循证意见书：肌萎缩侧（ALS）患者的物理和康复医学实践

国外神经内科相关专家小组（统称） · 2021-11-17

2021 循证意见书：肌萎缩侧索硬化（ALS）患者的物理和康复医学实践

国外神经内科相关专家小组（统称） · 2021-11-17

拓展阅读

2009 中国糖尿病护理及教育指南

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2009-10-30

2010CARI 2型糖尿病患者的肾功能评估

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010CARI 2型糖尿病患者中慢性肾脏病的预防和管理

澳大利亚肾病指南委员会(CARI,Caring for Australasians with Renal Impairment) · 2010-01-01

2010 AOA（POA）糖尿病患者眼部健康

美国视觉协会(AOA,American Optometric Association) · 2010-01-01

中国糖尿病医学营养治疗指南 （2010年）

中华医学会糖尿病学分会(CDS,Chinese Diabetes Society) · 2010-01-01

运动与2型糖尿病联合声明

美国糖尿病学会(ADA,American Diabetes Association) · 2010-01-01